Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04815356
What this trial is testing

Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant

Who this might be right for
Hairy Cell LeukemiaHairy Cell Leukemia Variant
National Cancer Institute (NCI) 27
Early research (Phase 1)WithdrawnNCT03782363
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Italian Sarcoma Group
Testing effectiveness (Phase 2)Looking for participantsNCT06940739
What this trial is testing

Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

Who this might be right for
Unresectable MelanomaMetastatic MelanomaOcular Melanoma
Iovance Biotherapeutics, Inc. 42
Early research (Phase 1)Not Yet RecruitingNCT07518654
What this trial is testing

Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma

Who this might be right for
Leukaemia (Acute Lymphoblastic)Leukaemia (Acute Myeloid)Neuroblastoma+7 more
Michel Duval 12
Testing effectiveness (Phase 2)Looking for participantsNCT07510802
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Who this might be right for
Breast Cancer (Advanced/Metastatic)HER2-positive Breast CancerTriple-negative Breast Cancer
Beijing Biotech 60
Very early researchStudy completedNCT02694783
What this trial is testing

Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells

Who this might be right for
Progressive Multifocal Leukoencephalopathy
National Institute of Neurological Disorders and Stroke (NINDS) 60
Early research (Phase 1)Active Not RecruitingNCT07809594
What this trial is testing

CS1-Targeted CAR-T Cells for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China 10
Early research (Phase 1)Active Not RecruitingNCT06767046
What this trial is testing

KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

Who this might be right for
ColorectalPancreaticNon-small Cell Lung Cancer (NSCLC)
Corregene Biotechnology Co., Ltd 8
Testing effectiveness (Phase 2)Ended earlyNCT00531310
What this trial is testing

Reduced Intensity AlloSCT in(CML) With Persistent Disease

Who this might be right for
Chronic Myeloid Leukemia
Columbia University 5
Testing effectiveness (Phase 2)Looking for participantsNCT07589530
What this trial is testing

Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid TumorsTROP2-Expressing Solid Tumors
Beijing Biotech 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07360288
What this trial is testing

Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
TICAROS Co., Ltd. 40
Early research (Phase 1)Study completedNCT02342613
What this trial is testing

Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematologic MalignanciesGraft-Versus-Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Early research (Phase 1)Ended earlyNCT04762225
What this trial is testing

RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanomaCervical Cancer
Repertoire Immune Medicines 7
Early research (Phase 1)UnknownNCT02366546
What this trial is testing

Investigator Initiated Phase 1 Study of TBI-1301

Who this might be right for
Solid Tumors
Mie University 9
Testing effectiveness (Phase 2)Study completedNCT01370213
What this trial is testing

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 25
Testing effectiveness (Phase 2)Study completedNCT02360579
What this trial is testing

Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Iovance Biotherapeutics, Inc. 220
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT04596033
What this trial is testing

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more
Genocea Biosciences, Inc. 49
Not applicableLooking for participantsNCT05646576
What this trial is testing

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Who this might be right for
Hematologic MalignancyBlood CancerLymphoma+2 more
Massachusetts General Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT05908643
What this trial is testing

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Neogap Therapeutics AB 16
Next Page